BeiGene Ltd. ADR [ONC] stock is trading at $230.98, up 1.24%. An important factor to consider is whether the stock is rising or falling in short-term value. The ONC shares have gain 10.88% over the last week, with a monthly amount drifted -13.25%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
BeiGene Ltd. ADR [NASDAQ: ONC] stock has seen the most recent analyst activity on April 07, 2025, when RBC Capital Mkts initiated its Outperform rating and assigned the stock a price target of $312. Previously, BofA Securities upgraded its rating to Buy on March 03, 2025, and elevated its price target to $320. JMP Securities started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $288 on September 18, 2024. Macquarie started tracking with a Outperform rating for this stock on September 12, 2023, and assigned it a price target of $259. In a note dated August 17, 2023, Jefferies initiated an Buy rating and provided a target price of $287 on this stock.
BeiGene Ltd. ADR [ONC] stock has fluctuated between $126.97 and $287.88 over the past year. Currently, Wall Street analysts expect the stock to reach $303.5 within the next 12 months. BeiGene Ltd. ADR [NASDAQ: ONC] shares were valued at $230.98 at the most recent close of the market. An investor can expect a potential return of 31.4% based on the average ONC price forecast.
Analyzing the ONC fundamentals
BeiGene Ltd. ADR [NASDAQ:ONC] reported sales of 3.81B for the trailing twelve months, which represents a growth of 77.78%. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -0.15%, Pretax Profit Margin comes in at -0.14%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.19 and Total Capital is -0.15. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.32.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 227.53 points at the first support level, and at 224.09 for the second support level. However, for the 1st resistance point, the stock is sitting at 234.29, and for the 2nd resistance point, it is at 237.60.
Ratios To Look Out For
For context, BeiGene Ltd. ADR’s Current Ratio is 1.80. On the other hand, the Quick Ratio is 1.58, and the Cash Ratio is 1.19. Considering the valuation of this stock, the price to sales ratio is 6.00, the price to book ratio is 7.40.
Transactions by insiders
Recent insider trading involved Wang Xiaodong, Chair, Scientific Advisory Brd, that happened on Apr 14 ’25 when 41760.0 shares were sold. Director, XIAODONG WANG completed a deal on Apr 14 ’25 to buy 0.13 million shares. Meanwhile, President, COO & GM China Wu Xiaobin sold 51921.0 shares on Apr 01 ’25.
